Hitoshi Endou
30Patents
4h-index
30Co-inventors
63Inventor score
Filing activity: Apr 22, 1991 → Nov 7, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7345068B2 | Aromatic amino acid derivatives and medicinal compositions | Emerging Cross-Sectional Technologies | 12 | Expired |
| US7943745B2 | Anti-CD98 antibody | Chemistry; Metallurgy | 9 | Active |
| US6986997B1 | Method for screening using an OAT1 transporter protein | Chemistry; Metallurgy | 8 | Expired |
| US9618512B2 | Biomarker for breast cancer | Chemistry; Metallurgy | 5 | Active |
| US6197806A | Eliminating agent for activated oxygen and free radicals | Human Necessities | 4 | Expired |
| US7138494B2 | Sodium-independent small neutral amino acid transporter transporting L- and D-amino acids | Chemistry; Metallurgy | 2 | Expired |
| US10005750B2 | Developing potent urate transporter inhibitors: compounds designed for their uricosuric action | Chemistry; Metallurgy | 2 | Active |
| US5174363A | Process for producing shape strips of metals | Performing Operations; Transporting | 1 | Expired |
| US8486402B2 | Anti-CD98 antibody | Chemistry; Metallurgy | 1 | Active |
| US7332572B1 | Neutral amino acid transporter and gene thereof | Human Necessities | 1 | Expired |
| US8236488B2 | Method of screening for therapeutic compounds for vascular disorders and hypertension based on URAT1 activity modulation | Emerging Cross-Sectional Technologies | 1 | Active |
| US10172835B2 | Anticancer agent composition | Chemistry; Metallurgy | 1 | Active |
| US7521570B2 | Medicinal compositions containing 6-hydroxybenzbromarone or salts thereof | Human Necessities | 1 | Expired |
| US7244556B2 | Method of modulating a testicular carnitine transporter | Chemistry; Metallurgy | 1 | Expired |
| US7393939B2 | Placental organic anion transporter and gene thereof | Chemistry; Metallurgy | 0 | Expired |
| US7335482B2 | Method using neutral amino acid transporter expressing cell | Human Necessities | 0 | Expired |
| US8039586B1 | Cerebral organic anion transporter and its gene | Chemistry; Metallurgy | 0 | Expired |
| US7582447B2 | DNA encoding a testicular carnitine transporter | Chemistry; Metallurgy | 0 | Active |
| US11899019B2 | Method for predicting efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy, method for evaluating cancer grade, and method for enhancing efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy | Physics | 0 | Active |
| US6673898B1 | Placental organic anion transporter | Chemistry; Metallurgy | 0 | Expired |
| US7332293B2 | Neutral amino acid transporter binding method | Human Necessities | 0 | Expired |
| US10173990B2 | URAT1 inhibitor | Chemistry; Metallurgy | 0 | Active |
| US7419790B2 | Sodium-independent transporter carrying acidic amino acid and its gene | Human Necessities | 0 | Expired |
| US7510847B2 | Kidney-specific urate transporter and gene thereof | Human Necessities | 0 | Active |
| US7307145B2 | Sodium-independent transporter transporting small-sized neutral amino acid, gene thereof and method of analyzing transporter function by constructing fused proteins enabling the specification of the function | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.